国际麻醉学与复苏杂志   2012, Issue (1): 0-0
    
腺病毒介导PPAR-γ1基因脑室内转染对大鼠缺血再灌注脑的保护作用
唐吉伟, 徐军美, 钱自亮1()
1.湖南省脑科医院麻醉科
The mechanism in the cerebral protective effect of PPAR-γ1 on the ischemia-reperfusion injury in rats
 全文:
摘要:

目的 1.研究通过脑室内途径腺病毒载体转染PPAR-γ1到脑的可行性,如果可行则进一步观察其对缺血再灌注脑是否具有保护作用。2.过表达PPAR-γ1基因和PPAR-γ激活剂吡格列酮合用,观察其对脑I/R保护作用是否有增强。 方法 选择95只成年雄性SD大鼠随机分成6组。按照包新民等报道的定位方法,在立体定位仪下给大鼠脑室内注射相应试剂0.1ml。第1、2组注入不含PPAR-γ1基因的生理盐水0.1ml,第3组注入Adv-PPARγ1 0.1ml,第4注入Adv-EGFP 0.1ml,第5组吡格列酮5mg/kg灌胃Qd3天,第6组脑室内注入Adv-PPARγ1 0.1ml+吡格列酮5mg/kg灌胃Qd3天。(3)3天后建立脑缺血再灌注模型。第1组为假手术组,不阻断大鼠大脑中动脉。第2-6组阻断大脑中动脉90分钟再灌注24小时。(4)采集脑组织标本,采用TTC染色法测量脑梗死体积;伊文氏蓝法测定血脑屏障通透性;干-湿重法测定脑含水量;光镜、电镜下进行病理形态学观察,免疫荧光显微镜下观察腺病毒表达情况;脑组织MPO活性测定;用Western Blot方法检测缺血区脑组织IL-1β、ICAM-1、AQP-4、MMP-9蛋白的表达。结果 脑室内途径腺病毒载体转染Adv-EGFP,免疫荧光反应阳性。脑缺血再灌注后,脑梗死体积、血脑屏障通透性、脑组织含水量、MPO活性明显增高,IL-1β、ICAM-1、AQP-4和MMP-9蛋白的表达增加。脑室内注射Adv-PPARγ1或吡格列酮灌胃均能抑制IL-1β、ICAM-1、AQP-4和MMP-9的上调。它们联合应用时能增强保护作用。结论 1. 通过脑室内注射腺病毒载体转染PPAR-γ1到脑的方法可行,且对缺血再灌注脑具有保护作用。脑室内转染PPAR-γ1基因和PPAR-γ激活剂吡格列酮合用,能增强对I/R脑的保护作用。

关键词: PPAR-γ1;脑缺血再灌注;基因转染
Abstract:

OBJECTIVE 1.To explore the feasibility of PPAR-γ1 gene transfection via cerebral ventricle and the protective effect against cerebral ischemia reperfusion injury. 2.To observe if the effection against cerebral ischemia reperfusion injury is enhanced when transfecting of PPAR-γ1 gene via cerebral ventricle association with the Pioglitazone which is PPAR-γ’s agonist. METHODS 95 S-D rats were randomly divided into 6 groups.Each group was treated with corresponding agent via cerebral ventricle.In groupⅠand Ⅱwere injected by normal saline.In group Ⅲ,rat was injected with 0.1ml Adv- PPAR-γ1 and the group Ⅳ was Adv-EGFP. The group Ⅴ was intragastric administered with Pioglitazone. The group Ⅵ was administered with PPAR-γ1 via cerebral ventricle and intragastric administered with Pioglitazone at the same time. 3. After 3 days middle cerebral artery occlusion model was established.The groupⅠwas sham-operation group.In group Ⅱ-Ⅵ middle cerebral artery was obstructed for 90min and followed reperfusion for 24h. 4. 24 hours after operation sample was collected and cerebral infarction volume was measured by TTC staining, blood brain barrier permeability by Evan’s blue dye Perfusion,brain moisture capacity by W-D weight method. To observe the pathomorphology by light microscope and electron microscope. Measuring the activity of MPO. To observe the expression of IL-1β、ICAM-1、AQP-4 and MMP-9 protein by Western Blotting. RESULTS After transfecting Adv-EGFP plasmid,the fluorescence for EGFP was positive in brain tissue suggesting the successful transfection of virus gene.In response to I/R injury, cerebral infarction was occurred.Blood brain barrier permeability、brain moisture capacity、the activity of MPO were dramatically incresed and the expression of IL-1β、ICAM-1、AQP-4、MMP-9 protein were upregulated.After injected Adv-PPAR-γ1 via cerebral ventricle or intragastric administered with Pioglitazone could inhibited the above parameters of injured brain.The improvement by adv-PPAR-γ1 gene and Pioglitazone was enhanced by administration together. CONCLUSIONS 1.Transfection of PPAR-γ1 gene via cerebral ventricle was feasible and demostrated the protectiv effect against cerebral ischemia reperfusion injury. 2. Combined transefction of PPAR-γ1 gene and intragastric administration with Pioglitazone could enhance the protectiv effect against cerebral ischemia reperfusion injury. 3. The infiltrations of neutrophilic leukocytes could be reduced by PPAR-γ1 and the expreeion of IL-1β、ICAM-1、AQP-4、MMP-9 protein were downregulated.These results suggests that the protective effect of PPAR-γ1 on ischemia-reperfusion injury is through regulating the inflammatory reaction and apoptosis.

Key words: PPAR-γ1;cerebral ischemia-reperfusion injury;gene transfection